HTA126 How Did French Health Technology Assessment Body (Transparency Committee, TC, of the HAS) Assess Drugs with Clinical Development Based on Single Arm Trials in the Last Three Years?
Abstract
Authors
P. Ravinet N. Aboussaid D. Chavade